Freenome Stock Forecast
NASDAQ: FRNMHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 15.78 0.00%
FRNM analyst consensus
Consensus (5 analysts)
none
Avg. price target
$18.00+14.07%
- Strong buy 0
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Freenome (2026-10-08), 5 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $18.00, with a high estimate of $21.00 and a low estimate of $17.00. The average target implies upside of 14.1% from the current price of $15.78.
The spread between the highest and lowest targets is 23.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for FRNM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 5 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $17.00 | +7.73% |
| Average target | $18.00 | +14.07% |
| High target | $21.00 | +33.08% |